BioNTech SE (BNTX) Receivables (2018 - 2026)
BioNTech SE's Receivables was $190.51 million in Q2 2026, down 87.8% from $1.56 billion a year earlier and down 69.8% from the prior quarter.
Powered by 
Analysis
BioNTech SE (BNTX) Receivables (2018 - 2026) Analysis & Trends
At the end of FY2025, Receivables at BioNTech SE came in at $1.08 billion, down 31.5% from FY2024.
- Receivables has now declined for four consecutive years, though with a five-year compound annual growth rate of 41.7% (FY2020 to FY2025).
- In earlier years, Receivables was $1.57 billion in FY2024 (-32.1%), $2.32 billion in FY2023 (-68.2%), $7.29 billion in FY2022 (-48.5%) and $14.16 billion in FY2021.
- The Q2 2026 figure marks the lowest quarterly Receivables since Q2 2024.
- Compared with a year earlier, Receivables has declined for four straight quarters, with an average decline of 44.0% over the last seven quarters.
- The best year-over-year quarter for Receivables over five years was Q1 2022 (growth of 393.2%); the worst was Q2 2024 (a decline of 97.0%).
- Per Business Quant data, BNTX's Receivables in the three quarters before Q2 2026 was $631.27 million (Q1 2026), $1.08 billion (Q4 2025) and $812.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | BioNTech SE | 25.06 Bn | -34.31 Bn | 10.00 Mn | 190.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 190.51 Mn |
| Mar 31, 2026 | 631.27 Mn |
| Dec 31, 2025 | 1.08 Bn |
| Sep 30, 2025 | 812.14 Mn |
| Jun 30, 2025 | 1.56 Bn |
| Mar 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 1.57 Bn |
| Sep 30, 2024 | 1.09 Bn |
| Jun 30, 2024 | 85.83 Mn |
| Mar 31, 2024 | 1.79 Bn |
| Dec 31, 2023 | 2.32 Bn |
| Sep 30, 2023 | 2.19 Bn |
| Jun 30, 2023 | 2.90 Bn |
| Mar 31, 2023 | 6.93 Bn |
| Dec 31, 2022 | 7.29 Bn |
| Sep 30, 2022 | 7.37 Bn |
| Jun 30, 2022 | 11.08 Bn |
| Mar 31, 2022 | 14.25 Bn |
| Dec 31, 2021 | 14.16 Bn |
| Sep 30, 2021 | 12.51 Bn |
API Access
BioNTech SE Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();